Recent insider trading activity from Achneck Hardean, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 8, 2024 | Aligos Therapeutics, Inc. | $ALGS | Achneck Hardean | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 79,900,000 | 9999.99% | 0.09% |